Iridex Corp (IRIX) is a publicly traded Healthcare sector company. As of May 20, 2026, IRIX trades at $1.07 with a market cap of $17.66M and a P/E ratio of 0.00. IRIX moved +3.45% today. Year to date, IRIX is -10.26%; over the trailing twelve months it is -1.87%. Its 52-week range spans $0.78 to $1.95. Analyst consensus is buy with an average price target of $2.75. Rallies surfaces IRIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
IRIX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IRIX recently traded at $1.07. Market cap is $17.66M. P/E ratio is 0.00. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $1.07 |
| Market Cap | $17.66M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.95 |
| 52-Week Low | $0.78 |
| Volume | 127.58K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $0 | $0 | $0.00 |
| 2024 | $48.67M | $-8.91M | $-0.54 |
| 2023 | $51.87M | $-9.57M | $-0.59 |
| 2022 | $53.90M | $-5.22M | $-0.34 |
1 analysts cover IRIX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.75.